Literature DB >> 7815094

Rational design of novel neurotensin mimetics: discovery of a pharmacologically unprecedented agent exhibiting concentration-dependent dual effects as antagonist and full agonist.

Y P Pang1, J Zaidi, A P Kozikowski, B Cusack, E Richelson.   

Abstract

We report the rational design of novel neurotensin mimetics through use of the Multiple Template Approach. This approach is based on our notion that a flexible peptide can be replaced by a partially flexible molecule, identified through testing a comparatively small number of molecules possessing a different intrinsic availability of conformations of the native peptide. The Multiple Template Approach has culminated in the discovery of a pharmacologically unprecedented agent, which behaves as a neurotensin antagonist at low concentration and as a full neurotensin agonist at high concentration.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7815094     DOI: 10.1007/bf00125377

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  22 in total

Review 1.  Constrained peptides: models of bioactive peptides and protein substructures.

Authors:  J Rizo; L M Gierasch
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

2.  Rapid agonist-induced decrease of neurotensin receptors from the cell surface in rat cultured neurons.

Authors:  M A Vanisberg; J M Maloteaux; J N Octave; P M Laduron
Journal:  Biochem Pharmacol       Date:  1991-11-27       Impact factor: 5.858

3.  Conformational restrictions of biologically active peptides via amino acid side chain groups.

Authors:  V J Hruby
Journal:  Life Sci       Date:  1982-07-19       Impact factor: 5.037

4.  Neurotensin and its analogs--correlation of specific binding with stimulation of cyclic GMP formation in neuroblastoma clone N1E-115.

Authors:  J A Gilbert; C J Moses; M A Pfenning; E Richelson
Journal:  Biochem Pharmacol       Date:  1986-02-01       Impact factor: 5.858

5.  Effects of CI-943, a potential antipsychotic drug, and haloperidol on regional brain neurotensin concentrations.

Authors:  B Levant; G Bissette; M D Davis; T G Heffner; C B Nemeroff
Journal:  Synapse       Date:  1991-11       Impact factor: 2.562

6.  Possible conformations involved in the binding of neurotensin, xenopsin and bradykinin molecules to mast cell receptors.

Authors:  L U Podinsh; G V Nikiforovich; G I Chipens
Journal:  FEBS Lett       Date:  1983-03-07       Impact factor: 4.124

7.  Neurotensin stimulates inositol phospholipid metabolism and calcium mobilization in murine neuroblastoma clone N1E-115.

Authors:  R M Snider; C Forray; M Pfenning; E Richelson
Journal:  J Neurochem       Date:  1986-10       Impact factor: 5.372

8.  Desensitization of neurotensin receptor-mediated cyclic GMP formation in neuroblastoma clone N1E-115.

Authors:  J A Gilbert; T R Strobel; E Richelson
Journal:  Biochem Pharmacol       Date:  1988-07-15       Impact factor: 5.858

9.  Further characterization of neurotensin receptor desensitization and down-regulation in clone N1E-115 neuroblastoma cells.

Authors:  M Yamada; M Yamada; E Richelson
Journal:  Biochem Pharmacol       Date:  1993-05-25       Impact factor: 5.858

10.  Conformational study of the neurotensin and substance P fragments: Pro-Arg-Arg-Pro and Arg-Pro-Lys-Pro.

Authors:  M Cotrait
Journal:  Int J Pept Protein Res       Date:  1983-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.